Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.

Background: The goal of this study was to identify a clinical biomarker signature of brain amyloidosis in the Alzheimer's Disease Neuroimaging Initiative 1 (ADNI1) mild cognitive impairment (MCI) cohort.Methods: We developed a multimodal biomarker classifier for predicting brain amyloidosis using co...

Full description

Bibliographic Details

Published in:	Neurology Vol. 84; no. 7; pp. 729 - 738
Main Authors:	Apostolova, Liana G, Hwang, Kristy S, Avila, David, Elashoff, David, Kohannim, Omid, Teng, Edmond, Sokolow, Sophie, Jack, Clifford R, Jagust, William J, Shaw, Leslie, Trojanowski, John Q, Weiner, Michael W, Thompson, Paul M
Format:	research Journal Article
Published:	Lippincott Williams & Wilkins 2/17/2015
Online Access:	View this record in EBSCOhost